EFSCE
LFCR icon

Enterprise Financial Services Corp (EFSC)’s Lifecore Biomedical LFCR Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-96
Closed -$1K – 1333
2020
Q3 		$1K Buy
+96
New +$914 ﹤0.01% 1189

Other funds holding LFCR

LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s LFCR Position: Q4 2020 in Review

Enterprise Financial Services Corp (EFSC) sold out of Lifecore Biomedical (LFCR) in Q4 2020, closing a stake of 96 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in LFCR in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 96 funds tracked by Wall St. Rank hold LFCR as of Q4 2020.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Lifecore Biomedical position as of Q4 2020 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 96 Lifecore Biomedical shares in Q4 2020, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Lifecore Biomedical in Q3 2020 and held it in 1 quarter.
  • Enterprise Financial Services Corp (EFSC)'s Lifecore Biomedical position peaked at $1K in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2020.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2020, filed 12 Feb 2021.